MSD pharmaceuticals Pvt. Ltd.

Last updated: 13.02.2014

Address: Platina, 8th Floor, C.59, G Block, Bandra Kurla Complex, Bandra (East) , Mumbai – 400098,

Tel: +91 22 67898888

Web: http://www.msdindia.in/

Company description

About Merck

Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A, is a global healthcare leader working towards providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and creating long term shareholder value. Post its merger with Schering‐Plough in November 2009, Merck is now the second largest pharmaceutical company in the world.

Merck offers a diversified portfolio of prescription medicines, vaccines and animal and consumer health products. This portfolio is complemented by a robust pipeline with more than 15 promising late‐stage candidates spanning critical therapeutic categories. Merck now has approximately 106,000 employees and operates in more than 140 countries around the world. Merck anticipates sales from emerging markets to make up more than 25 percent of its global sales by 2013.

The company takes advantage of the combined strengths of Merck and Schering‐Plough to create a more customer‐focused, innovative, and diversified global health care company positioned to capitalize on the company’s greatest opportunities for growth, particularly in emerging markets, biologics and vaccines. Merck has five primary divisions: Global Human Health, Animal Health, Consumer Health Care, Merck Research Laboratories and Merck Manufacturing.

Key Therapeutic Areas

Merck has a broad portfolio of medicines – the company’s diverse portfolio of adult, adolescent and pediatric vaccines and medicines spans important therapeutic areas, including cardiovascular, diabetes, obesity, bone, respiratory, immunology, dermatology, infectious disease, oncology, neurosciences, ophthalmology, women’s health and endocrinology. This is in addition to a powerful late stage global pipeline of 20 late‐stage compounds.

Merck is known as MSD in all markets outside USA and Canada.

MSD India

MSD, operates in India via three separate legal entities MSD Pharmaceuticals Pvt. Ltd., Organon India Limited and Fulford India Limited., which are subsidiaries of Merck & Co. Inc. USA. Since its existence in India, the company has moved quickly in laying the foundation for a business that is differentiated by its focus on putting patients first and launching innovative products those are relevant to India. MSD India currently operates in various therapeutic areas including Metabolics, Cardiovascular, Vaccines, Critical Care, Immunology, Virology, Oncology, Women’s Health, Dermatology, Respiratory, Muskulotology and Primary Care.

Post operational integration between the legacy companies, the new MSD India offers a stronger and diversified product portfolio of over 75 brands in various therapeutic areas, of which 13 are already category leading products. The integration has brought together the best and brightest talent in the industry.

Commitment to India

MSD has a long term commitment to India both in terms of bringing best in class products and also making necessary investments to serve the Indian patients. MSD will continue in its endeavor to shape the healthcare paradigms in India via initiatives like responsible pricing, integrated disease management programmes; amongst others. MSD aims to be amongst the top 5 pharmaceutical companies in India, by 2015.

In addition to setting up a sales and marketing structure to market its best in class products in India, MSD is also coordinating research projects with clinical investigators in India’s leading hospitals and universities, for development on new drugs to address unmet medical needs for Indian patients.

As a testimonial to MSD’s scientific excellence the Indian Council of Medical Research (ICMR) has signed the first public private partnership with MSD.

Caring for the society we serve

MSD embraces a commitment to its stakeholders, employees, neighbors, and others in the global communities where it lives and works. Its commitment is demonstrated by its work in more than 140 countries worldwide, through its philanthropic initiatives and ethical business practices.

For over 100 years MSD has produced The Merck Manual, one of many initiatives to inform health related decision making that also include the Merck Institute of Aging & Health and the Merck Vaccine Network. MSD builds high environmental and safety standards into all of its processes and activities and promotes continuous improvement.

MSD Wellcome Trust Hilleman Laboratories ‐ a joint venture between MSD and Hilleman Laboratories is a first of its kind research and development joint venture with a not‐for‐profit mission to focus on developing affordable vaccines to prevent diseases that commonly affect low income countries.

Products and services

Please see above

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here